Management of peri-implantitis: a systematic review, 2010–2015
© Mahato et al. 2016
Received: 16 October 2015
Accepted: 18 January 2016
Published: 1 February 2016
Peri-implantitis or Periimplantitis is characterized as an inflammatory reaction that affects the hard and soft tissue, which results in loss of supporting bone and pocket formation surrounding the functioning osseointegrated implant. This review aimed to evaluate the effectiveness of surgical and non-surgical treatment of peri-implantitis. The data sources used was PubMed. Searches of this database were restricted to English language publications from January 2010 to June 2015. All Randomized Controlled Trials describing the treatments of peri-implantitis of human studies with a follow up of at least 6 months were included. Eligibility and quality were assessed and two reviewers extracted the data. Data extraction comprised of type, intensity provider, and location of the intervention. A total of 20 publications were included (10 involving surgical and 10 involving non-surgical mechanical procedure). The non-surgical approach involves the mechanical surface debridement using carbon or titanium currettes, laser light, and antibiotics whereas, surgical approach involves implantoplasty, elevation of mucoperiosteal flap and removal of peri-inflammatory granulation tissue followed by surface decontamination and bone grafting. This study reveals that non-surgical therapy tends to remove only the local irritant from the peri-implantitis surface with or without some additional adjunctive therapies agents or device. Hence, non-surgical therapy is not helpful in osseous defect. Surgical therapy in combination with osseous resective or regenerative approach removes the residual sub-gingival deposits additionally reducing the peri-implantitis pocket. Although there is no specific recommendation for the treatment of peri-implantitis, surgical therapy in combination with osseous resective or regenerative approach showed the positive outcome.
KeywordsPeri-implantitis treatment Surgical and non-surgical therapy Dental implant bone loss
Implant based dental rehabilitation technique has come to offer steadfast result hence it has become a cardinal entrenched therapy in order to restore missing natural teeth in regular clinical practice. van Velzen et al. (2014) has reported 91.6 % of success rate for dental implant and shows 7 % of peri-implantitis after 10 years follow up. Dental implant has majority of success rate in long term however failure does occur. Peri-implant disease which is commenced by bacteria have two subtypes (1) Peri-implant mucositis and (2) Peri-implantitis. Peri-implant mucositis is the reversible inflammatory process of the soft tissue surrounding the peri-implant, which is followed by reddening, swelling and bleeding on probing (Mombelli et al. 2012).
Classification of peri-implantitis (Froum and Rosen 2012)
PD ≥4 mm (bleeding and/or suppuration on probing)a
Bone loss <25 % of the implant lengthb
PD ≥6 mm (bleeding and/or suppuration on probing)a
Bone loss <25–50 % of the implant lengthb
PD ≥8 mm (bleeding and/or suppuration on probing)a
Bone loss >50 % of the implant lengthb
Implant failure could be due to imbalanced occlusal force, smoking habit, poor bone quality, implant thread design, improper surgical placement, surgical trauma, incorrect prosthetic design, poor oral hygiene, bacterial infection, diabetes, the particles released from implant, etc. Bacterial infection is considered as the most important factor for implant failure. Microbiota associated with peri-implantitis are Prevotella intermedia, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Bacterioides forsythus, Treponema denticola, Prevotella nigrescens, Peptostreptococcus micros, Fusobacterium nucleatum, etc. (Ata-Ali et al. 2011).
Peri-implantitis is latent in early stage and usually diagnosed during routine dental check up. Hence early diagnosis of peri-implantitis is very important to terminate the further progression of the diseases and for establishment of good osseointegration. Various treatment modalities have been put forward for the treatment of peri-implantitis, which are summarized in two treatment methods, namely resective and regenerative therapies. Resective implant treatment attempts to eliminate the etiologic factors and maintain optimal peri-implant conditions, mainly by cleaning the surfaces of the implants; whereas regenerative periodontal therapy (using bone grafts, membranes and growth factors) aims to regenerate a new attachment apparatus and reconstruct the periodontal unit to previously existing normal physiologic limits (Kim et al. 2011; Smeets et al. 2014). An optimal objective of peri-implantitis management should be the eradication of the diseases (no bleeding on probing, no further bone loss) and formulation of hard and soft peri-implant tissue. This review aims to evaluate the ideal surgical treatment of peri-implantitis in humans in a broader way than previous studies.
The aim of the present study is to assess the effectiveness of treatment of peri-implantitis.
Rationale and focused question
To our knowledge from indexed literature, there is no absolute explanation regarding the effectiveness of surgical and non-surgical management of peri-implantitis.
The addressed focused question is: “What is the recommended treatment for management of peri-implantitis?”
Search methods to identify relevant studies (Table 2)
Systematic search strategy
What is the recommended treatment for management of peri-implantitis?
Patients diagnosed with peri-implantitis
Intervention or Exposure
Non-surgical treatment with surgical treatment
Resolution of disease: implant survival and absence of PD ≥4 mm with suppuration/BoP and no further bone loss
Peri-implantitis treatment, bone grafting peri-implantitis, therapy peri-implantitis, dental implant bone loss, dental implant inflammation
Include patients with at least one dental osseointegrated implant affected by peri-implantitis
Describe a clinical intervention aiming at the treatment of the condition
Describe a pathological condition of peri-implantitis with bone loss
Experimental human studies
Full-text articles (Randomized and Controlled Clinical Trials)
Follow up of at least 6 months
No access to an English version of title and abstract
The following eligibility criteria were imposed: (1) Original articles; (2) Experimental human studies; (3) Reference list of pertinent original and review studies; (4) Intervention: Effectiveness of peri-implantitis after surgical and non-surgical treatment; (5) Articles published only in English-language; and (6) Full-text articles (Randomized and Controlled Clinical Trials). Letters to the editor, historic reviews, abstract with no full text articles and unpublished articles were excluded.
Data extraction and quality assessment
Surgical and non-surgical experimental studies of dental implants following treatment of peri-implantitis
Diagnosis of peri-implantitis
No. of implant
Schar et al. (2013)
PPD 4–6 mm
Bone loss—0.5–2 mm
Minocycline Microspheres locally
Modified plaque index
Both treatment equally effective but no complete resolution of inflammation
Schwarz et al. (2006b)
PD 4 mm
Keratinized peri-implant mucosa
Improved clinical parameters
Mixed chronic inflammatory cell infiltrate
PD ≥4 mm
Bleeding/pus on probing
Bone loss ≤1.8 mm
Minocycline microspheres locally 1 mg
1 % chlorhexidine gel
Local plaque index
Both treatment resulted marked reduction in indicator bacteria
Minocycline treatment improved PD
Persson et al. (2010)
PPD ≥4 mm
Bone loss >2.5 mm
Bleeding/pus on probing
Both methods failed to eliminate bacterial counts
Hallstrom et al. (2012)
PPD ≥4 mm
Bleeding/pus on probing
BOP and PPD were improved with antibiotic treatment
No changes in bacterial count in both groups
Sahm et al. (2011)
PPD ≥4 mm
Bone loss ≤30 %
No occlusal overload
2 mm keratinized attached mucosa
OHI (Oral Hygiene Instructions)
Amino acid glycine powder (AAD)
Mechanical debridement with carbon curettes
Antiseptic therapy chlorhexidine digluconate (MDA)
Both groups revealed comparable PD reduction and CAL gains
Higher changes in BOP in AAD group
PPD ≥5 mm
Bone loss ≥2 mm
Both method showed limited clinical improvement but failed to reduce bacterial count.
Karring et al. (2005)
PPD ≥5 mm
Bone loss ≥1.5 mm
Vector ® system
Submucosal debridment with carbon fiber curette
There was no significant difference between the two methods although BOP was reduced in Vector ® system
Machtei et al. (2012)
PD 6–10 mm
Matrix chips (MatrixC)
Chlorhexidine chips (PerioC)
PerioC showed greater clinical improvement than MatrixC
Aghazadeh et al. (2012)
PD ≥5 mm
Bone loss ≥3 mm
Bovine derived xenograft (BDX)
BDX with collagen membrane showed more radiographic bone defect fill
Bothe treatment offered improvement in BOP, PD and suppuration
PD >6 mm
Bone loss >3 mm
Access flap surgery
Access flap surgery
Natural bone mineral
24 months and 4 years
Natural bone plus membrane offered better result
Schwarz et al. (2006a)
PD >6 mm
Bone loss >3 mm
Access flap surgery
Access flap surgery
Bovine derived xenograft
Both treatment offered PD reduction and CAL gain
Wohlfart et al. (2012)
PD ≥5 mm
Bone loss ≥4 mm
Resective surgery using titanium curettes
24 % ethylenediaminetetraacetic acid
Resective surgery using titanium curettes
Porous titanium granules (PTG)
Reconstruction with PTG resulted better radiographic peri-implant defect fill
Romeo et al. (2007)
PD ≥4 mm
No implant mobility
Radiographic horizontal peri-implant radiolucency
Amoxicillin 50 mg/kg prior to treatment for 8 days
Amoxicillin50 mg/kg prior to treatment for 8 days
Marginal bone loss
Radiographs revealed implantoplasty as an effective treatment
PD >6 mm
Intrabony defect >3 mm-
2 mm Keratinized mucosa
26 and 38
Er:YAG laser in intra bony components
Natural bone Mineral
Cotton pellets dipped in sterile saline (CPS)
Natural bone mineral
6 and 24 months
24 months treatments with CPS offered better clinical parameters as well as bony defect fill
de Waal et al. (2013)
PD ≥5 mm
Bone defect ≥2 mm
Resective surgery with apically repositioned flap
0.12 % chlorhexidine
0.05 % cetylpyrinidium chloride (CPC)
CHX + CCP treatment results immediate suppression of bacterial count
A meta-analysis of trial data was not possible due to heterogeneity in trial design and outcomes reported. Data related to trial quality was therefore subject to narrative synthesis. Trial quality was assessed using the Critical Appraisal Skills Programme and PRISMA-2009 Checklist.
Risk of bias included in studies
There could be potential language bias in this systematic review as we only considered literature written in English.
Using the search strategy above, 2253 articles were retrieved. After reviewing title and abstracts, 2230 of those articles were excluded and 23 studies were included because the focus of this review is randomized controlled trials on therapy of peri-implantitis (Fig. 1). Among 23 studies, we excluded 2 because these 2 studies did not meet the criteria to diagnose peri-implantitis and another 1 study which failed to meet the criteria of at least 6 month follow up. In total, 20 articles were included in this review. The pattern of the current review was customized to mainly summarize the pertinent information.
Description of eligible studies
Treatment of peri-implantitis
Bio-film and bacteria on the surface of implant plays an important role in the appearance of peri-implantitis (Canullo et al. 2015). The management of peri-implantitis is focused on infection and bacterial controls. The treatments proposed for peri-implant disease are based on the evidence gained from the treatment of periodontitis. Both surgical and non-surgical techniques have been developed for the treatment of peri-implantitis.
The treatment of peri-implantitis in the case of incipient bone loss involves the elimination of local irritants with or without surface decontamination, systemic antibiotics, some additional adjunctive therapies agents or devices (Machtei 2014).
In the articles included in our review (Table 3), a total of 730 patients were treated with a follow up period of 6 months to 4 years with a pocket depth of >4 mm, radiological confirmed bone loss of ≥1.5 mm, exposed implant thread, absence of mobility and the presence of bacteria.
The studies compared ultrasound and carbon fiber curettes; curettage with or without antibiotics; conventional scaling and the Er:YAG laser.
Karring et al. (2005) compared the treatment results obtained with the Vector® ultrasound system and with carbon fiber curettes. After 6 months of follow-up, no significant differences were found between the two techniques, and neither proved sufficient to treat peri-implantitis. Same results were obtained by Persson et al. (2010) with titanium curettes and with ultrasonic device. After 6 month of follow up, no differences were found to reduce microbiota neither proved sufficient to treat peri-implantitis.
The study conducted by Sham et al. (2011) compared mechanical debridement using carbon curettes and antiseptic therapy (MDA) with amino acid glycine powder (AAD). After 6 months of follow up treatment both study group resulted in limited clinical attachment level and the bleeding was reduced in AAD group as compared to MDA group.
Schwarz et al. (2006b), Renvert et al. (2011) and Persson et al. (2011) compared the Er:YAG laser with air abrasive device. The author recorded limited improvement in clinical parameters in both the group but the bacterial count was not reduced after 6 month of follow up.
Mechanical treatments associated to antibiotics
The two studies of Renvert et al. (2006, 2008) published in the year 2006 and 2008 evaluated the treatment in 32 patients, comparing local minocycline microspheres and chlorhexidine gel debridement. After 1 year of treatment both study group showed improvement in plaque index, pocket depth and bleeding without improvement in terms of microbiota. In relation to bacterial load, there were no differences in the change in bacterial composition in the two groups after treatment and further studies were needed to establish how often such treatment must be repeated. Similarly Schar et al. (2013) examined the benefit of photodynamic therapy (PDT) over minocycline microspheres. In both group significant reductions in mucosal inflammation was observed up to 6 month.
The studies published by Hallstrom et al. (2012) in 2012 had used systemic antibiotic azithromycin for 4 days. After 6 months of follow up, there was improvement only in oral hygiene but this study could not provide evidence.
Machtei et al. (2012) evaluated and compared the matrix chips (MatrixC) with that of chlorhexidine chips (PerioC) in 60 patients with probing depth 6–10 mm and bone loss >2 mm. The results yields after 6 month of repeated treatment shows probing depth reduction was greater in the PerioC (2.19 ± 0.24 mm) compared with MatrixC (1.59 ± 0.23 mm). Half in both groups reduced bleeding on probing. Clinical attachment level gains for both groups were significant. However, to fully appreciate mechanism of this treatment, a further study is needed.
Surgical treatment of peri-implantitis lesions may be performed in cases with considerable pocket formation (larger than 5 mm) and bone loss. Surgical techniques can be divided into resective and regenerative surgery. These techniques is used depending upon the type of bony defects whereas Schwarz et al. (2014) have demonstrated that combined surgical procedure is effective in controlling advanced peri-implantitis lesion.
Aghazadeh et al. (2012) concluded that resective surgical procedures coupled with bovine derived xenograft and placement of collagen membrane have more radiographic evidence of bony defect filled as compared to autogenous bone graft.
The 2-years result by Schwarz et al. (2008) demonstrated that both nanocrystalline hydroxyapatite and application of the combination of natural bone mineral and collagen membrane were efficacious in providing clinical significant reduction of the pocket probing depth and gain in clinical attachment level but in the 4 year study of Schwarz et al. (2009) application of the combination of natural bone mineral and collagen membrane were more efficacious in clinical improvement as compared to nanocrystalline hydroxyapatite. But the 6 months of Schwarz et al. (2006a) study concluded the application of nanocrystalline hydroxyapatite and guided tissue regeneration showed significant improvement in clinical parameters.
Wohlfahrt et al. (2012) evaluated the 12 months outcome by adding porous titanium granules (PTG) together with an open flap procedure and in conjunction with mechanical debridement of the implant surface for decontamination with 24 % ethylenediaminetetracetic acid gel followed by antibiotics (amoxicillin and metronidazole) 3 days prior to surgery and for 7 days after surgery. Both the treatment demonstrated significant improvements in probing pocket depth but the reconstruction with PTG resulted in better radiographic peri-implant defect fill.
Romeo et al. (2007) have compared the efficacy of resective surgery with that of implantoplasty. The results obtained after 3 years of therapy demonstrated that the marginal bone loss was significantly lower after implantoplasty.
Schwarz et al. (2011, 2012) in two studies (2011 and 2012) of advanced peri-implantitis evaluated and compared the efficacy of Er:YAG laser (ERL) surface debridement/decontamination (DD) with that of plastic curettes and cotton pellets (CPS) soaked in sterile saline and both procedure were followed by an implantoplasty at the exposed implant surface and were augmented with a natural bone mineral and covered with a collagen membrane. After 24 months of treatment, CPS group yield significant reduction in bleeding on probing and the radiographic bone fill at the intra-bony defect were same in both groups but the clinical attachment values were not significantly different in both groups.
The study by de Waal et al. (2013) demonstrated that the adjunctive benefits derived from the addition of resective surgical treatment consisting of apically re-positioned flap, bone re-contouring and surface debridement and with 0.12 % CHX + 0.05 % CPC to a placebo-solution (without CHX/CPC) tend to be greater immediate suppression of anaerobic bacteria on the implant surface than a placebo-solution, but does not lead to superior clinical results.
The treatment protocol differs depending upon whether it is peri-implant mucositis or peri-implantitis. Until now, no particular treatment protocol has been shown effective. There are number of treatment protocol for the resolution of diseases. But this study highlighted that diseases resolution is satisfactory by surgical treatment. Peri-implant mucositis can be treated by non-surgical treatment (Schar et al. 2013). If the peri-implantitis is diagnosed then the treatment protocol depends on the intraosseous defect. If the bony defect is minimum then implantoplasty can improve the bony defect (Romeo et al. 2007).
Non-surgical treatment could improve significant clinical parameters but bacterial pathogens are not reduced. Treatment standard of peri-implantits can be improved by decreasing the bacterial pathogen hence it is effective if resective surgery is followed in the incipient case of peri-implantitis as well.
In the advanced peri-implantitis combined treatment of resective and regenerative surgical procedure followed by surface decontamination yields good osseo-integration (Schwarz et al. 2012). de Waal et al. (2013) study concluded that surface decontamination/debridement reduce bacterial count but there was no superior improvement in clinical parameters hence guided bone regeneration (Aghazadeh et al. 2012) or the application of bone substitute (Schwarz et al. 2009) (nanocrystalline hydroxyapetite) can be efficacious for the treatment of peri-implantitis. The majority of surgical protocols include pre-operative or post-operative systemic antibiotics followed by post-operative chlorhexidine rinse. Maintenance phase after surgery is also important which include oral hygiene instructions and surface biofilm removal.
Although we performed a comprehensive analysis of the effects of surgical and non-surgical treatment, there were some limitations to this systematic review. First, our systematic review could not provide the implant survival rate because of insufficient eligible information. Second, high quality study with survival rate was not there which may compromise our conclusion. There could be potential language bias in this systematic review as we only considered literature written in English.
Complete osseointegration is difficult to achieve. Even though the different treatment modalities cannot be comparable, however the outcome of surgical treatment of peri-implantitis is good. Surgical procedures for peri-implantitis in human have shown positive results but long-term study is needed to achieve the reliability of the treatment.
NM, WX and WL have contributed for conception and design of study. NM and WX have contributed for acquisition of data. NM, WL and WX have contributed for analysis and interpretation of the data. NM, WL and WX have revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
This study was supported by grant from the National Natural Science Foundation of China (No 81200767/H1402).
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Aghazadeh A, Rutger Persson G, Renvert S (2012) A single-centre randomized controlled clinical trial on the adjunct treatment of intra-bony defects with autogenous bone or a xenograft: results after 12 months. J Clin Periodontol 39(7):666–673. doi:10.1111/j.1600-051X.2012.01880.x View ArticleGoogle Scholar
- Ata-Ali J, Candel-Marti ME, Flichy-Fernandez AJ, Penarrocha-Oltra D, Balaguer-Martinez JF, Penarrocha Diago M (2011) Peri-implantitis: associated microbiota and treatment. Med Oral Patol Oral Cir Bucal 16(7):e937–e943View ArticleGoogle Scholar
- Canullo L, Penarrocha-Oltra D, Covani U, Rossetti PH (2015) Microbiologic and clinical findings of implants in healthy condition and with peri-implantitis. Int J Oral Maxillofac Implants 30(4):834–842. doi:10.11607/jomi.3947 View ArticleGoogle Scholar
- de Waal YC, Raghoebar GM, Huddleston Slater JJ, Meijer HJ, Winkel EG, van Winkelhoff AJ (2013) Implant decontamination during surgical peri-implantitis treatment: a randomized, double-blind, placebo-controlled trial. J Clin Periodontol 40(2):186–195. doi:10.1111/jcpe.12034 View ArticleGoogle Scholar
- Froum SJ, Rosen PS (2012) A proposed classification for peri-implantitis. Int J Periodontics Restorative Dent 32(5):533–540Google Scholar
- Hallstrom H, Persson GR, Lindgren S, Olofsson M, Renvert S (2012) Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trial. J Clin Periodontol 39(6):574–581. doi:10.1111/j.1600-051X.2012.01884.x View ArticleGoogle Scholar
- Karring ES, Stavropoulos A, Ellegaard B, Karring T (2005) Treatment of peri-implantitis by the Vector system. Clin Oral Implants Res 16(3):288–293. doi:10.1111/j.1600-0501.2005.01141.x View ArticleGoogle Scholar
- Kim DM, Nevins M, Camelo M, Schupbach P, Kim SW, Camelo JM, Al Hezaimi K, Nevins ML (2011) The feasibility of demineralized bone matrix and cancellous bone chips in conjunction with an extracellular matrix membrane for alveolar ridge preservation: a case series. Int J Periodontics Restorative Dent 31(1):39–47Google Scholar
- Machtei EE (2014) Treatment alternatives to negotiate peri-implantitis. Adv Med 2014:13. doi:10.1155/2014/487903 View ArticleGoogle Scholar
- Machtei EE, Frankenthal S, Levi G, Elimelech R, Shoshani E, Rosenfeld O, Tagger-Green N, Shlomi B (2012) Treatment of peri-implantitis using multiple applications of chlorhexidine chips: a double-blind, randomized multi-centre clinical trial. J Clin Periodontol 39(12):1198–1205. doi:10.1111/jcpe.12006 View ArticleGoogle Scholar
- McCrea SJ (2014) Advanced peri-implantitis cases with radical surgical treatment. J Periodontal Implant Sci 44(1):39–47. doi:10.5051/jpis.2014.44.1.39 View ArticleGoogle Scholar
- Mombelli A, Muller N, Cionca N (2012) The epidemiology of peri-implantitis. Clin Oral Implant Res 23(Suppl 6):67–76. doi:10.1111/j.1600-0501.2012.02541.x View ArticleGoogle Scholar
- Persson GR, Samuelsson E, Lindahl C, Renvert S (2010) Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II. Microbiological results. J Clin Periodontol 37(6):563–573. doi:10.1111/j.1600-051X.2010.01561.x View ArticleGoogle Scholar
- Persson GR, Roos-Jansaker AM, Lindahl C, Renvert S (2011) Microbiologic results after non-surgical erbium-doped:yttrium, aluminum, and garnet laser or air-abrasive treatment of peri-implantitis: a randomized clinical trial. J Periodontol 82(9):1267–1278. doi:10.1902/jop.2011.100660 View ArticleGoogle Scholar
- Renvert S, Lessem J, Dahlen G, Lindahl C, Svensson M (2006) Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. J Clin Periodontol 33(5):362–369. doi:10.1111/j.1600-051X.2006.00919.x View ArticleGoogle Scholar
- Renvert S, Lessem J, Dahlen G, Renvert H, Lindahl C (2008) Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol 79(5):836–844. doi:10.1902/jop.2008.070347 View ArticleGoogle Scholar
- Renvert S, Lindahl C, Roos Jansaker AM, Persson GR (2011) Treatment of peri-implantitis using an Er:YAG laser or an air-abrasive device: a randomized clinical trial. J Clin Periodontol 38(1):65–73. doi:10.1111/j.1600-051X.2010.01646.x View ArticleGoogle Scholar
- Romeo E, Lops D, Chiapasco M, Ghisolfi M, Vogel G (2007) Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part II: radiographic outcome. Clin Oral Implant Res 18(2):179–187. doi:10.1111/j.1600-0501.2006.01318.x View ArticleGoogle Scholar
- Sahm N, Becker J, Santel T, Schwarz F (2011) Non-surgical treatment of peri-implantitis using an air-abrasive device or mechanical debridement and local application of chlorhexidine: a prospective, randomized, controlled clinical study. J Clin Periodontol 38(9):872–878. doi:10.1111/j.1600-051X.2011.01762.x View ArticleGoogle Scholar
- Schar D, Ramseier CA, Eick S, Arweiler NB, Sculean A, Salvi GE (2013) Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: six-month outcomes of a prospective randomized clinical trial. Clin Oral Implant Res 24(1):104–110. doi:10.1111/j.1600-0501.2012.02494.x View ArticleGoogle Scholar
- Schwarz F, Bieling K, Latz T, Nuesry E, Becker J (2006a) Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series. J Clin Periodontol 33(7):491–499. doi:10.1111/j.1600-051X.2006.00936.x View ArticleGoogle Scholar
- Schwarz F, Bieling K, Nuesry E, Sculean A, Becker J (2006b) Clinical and histological healing pattern of peri-implantitis lesions following non-surgical treatment with an Er:YAG laser. Lasers Surg Med 38(7):663–671. doi:10.1002/lsm.20347 View ArticleGoogle Scholar
- Schwarz F, Sculean A, Bieling K, Ferrari D, Rothamel D, Becker J (2008) Two-year clinical results following treatment of peri-implantitis lesions using a nanocrystalline hydroxyapatite or a natural bone mineral in combination with a collagen membrane. J Clin Periodontol 35(1):80–87. doi:10.1111/j.1600-051X.2007.01168.x View ArticleGoogle Scholar
- Schwarz F, Sahm N, Bieling K, Becker J (2009) Surgical regenerative treatment of peri-implantitis lesions using a nanocrystalline hydroxyapatite or a natural bone mineral in combination with a collagen membrane: a four-year clinical follow-up report. J Clin Periodontol 36(9):807–814. doi:10.1111/j.1600-051X.2009.01443.x View ArticleGoogle Scholar
- Schwarz F, Sahm N, Iglhaut G, Becker J (2011) Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical study. J Clin Periodontol 38(3):276–284. doi:10.1111/j.1600-051X.2010.01690.x View ArticleGoogle Scholar
- Schwarz F, John G, Mainusch S, Sahm N, Becker J (2012) Combined surgical therapy of peri-implantitis evaluating two methods of surface debridement and decontamination. A two-year clinical follow up report. J Clin Periodontol 39(8):789–797. doi:10.1111/j.1600-051X.2012.01867.x View ArticleGoogle Scholar
- Schwarz F, Sahm N, Becker J (2014) Combined surgical therapy of advanced peri-implantitis lesions with concomitant soft tissue volume augmentation. A case series. Clin Oral Implant Res 25(1):132–136. doi:10.1111/clr.12103 View ArticleGoogle Scholar
- Smeets R, Henningsen A, Jung O, Heiland M, Hammacher C, Stein JM (2014) Definition, etiology, prevention and treatment of peri-implantitis—a review. Head Face Med 10:34. doi:10.1186/1746-160X-10-34 View ArticleGoogle Scholar
- van Velzen FJ, Ofec R, Schulten EA, Ten Bruggenkate CM (2014) 10-Year survival rate and the incidence of peri-implant disease of 374 titanium dental implants with a SLA surface: a prospective cohort study in 177 fully and partially edentulous patients. Clin Oral Implant Res. doi:10.1111/clr.12499 Google Scholar
- Wohlfahrt JC, Lyngstadaas SP, Ronold HJ, Saxegaard E, Ellingsen JE, Karlsson S, Aass AM (2012) Porous titanium granules in the surgical treatment of peri-implant osseous defects: a randomized clinical trial. Int J Oral Maxillofac Implants 27(2):401–410Google Scholar